Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Choroid Plexus Volume Changes in Multiple Sclerosis: Insights From a Systematic Review and Meta-Analysis of Magnetic Resonance Imaging Studies Publisher Pubmed



Kolahi S1 ; Zarei D1 ; Issaiy M1 ; Shakiba M1 ; Azizi N1 ; Firouznia K1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences, Tehran, Iran

Source: Neuroradiology Published:2024


Abstract

Purpose: Multiple sclerosis (MS) is a chronic autoimmune disease characterized by the destruction of the myelin sheath within the central nervous system. The etiology of MS involves a complex interplay of genetic, environmental, and immunological factors. Recent studies indicated the potential role of the choroid plexus (CP) in the pathogenesis and progression of MS. This systematic review aims to assess existing research on the volume alterations of the CP in MS patients compared to the normal population. Methods: A comprehensive search was conducted across databases including PubMed, Embase, Scopus, and Web of Science up to June 2024. Data from the included studies were synthesized using a meta-analytical approach with a random-effects model, assessing heterogeneity with the I2 and Tau-squared indices. Results: We included 17 studies in this systematic review. The meta-analysis, which included data from eight studies reporting CP volume relative to TIV, found a statistically significant increase in CP volume in MS patients compared to healthy controls (HCs). The SMD was 0.77 (95% CI: 0.61 to 0.93), indicating a large effect size. This analysis showed no heterogeneity (I² = 0%). A separate meta-analysis was conducted using five studies that reported CP volume as normalized volume, resulting in an SMD of 0.63 (95% CI: 0.2–1.06). Conclusion: This study demonstrates an increase in CP volume among MS patients compared to HCs, implying the potential involvement of CP in MS pathogenesis and/or progression. These results show that CP might serve as a radiological indicator in the diagnosis and prognosis of MS. © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024.
Related Docs
View other Related Docs
1. Current Advances in Stem Cell Therapy in the Treatment of Multiple Sclerosis, Reviews in the Neurosciences (2023)
2. Recent Advances in Mesenchymal Stem Cell Therapy for Multiple Sclerosis: Clinical Applications and Challenges, Frontiers in Cell and Developmental Biology (2025)
3. Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence, Clinical Drug Investigation (2019)
4. Impact of Supplementation With Multivitamin-Mineral Specially Formulated to Improve Fatigue and Inflammatory State in Patients With Multiple Sclerosis: A Triple-Blind, Randomized, Placebo-Controlled Trial, Current Journal of Neurology (2020)
5. A Focus on Allogeneic Mesenchymal Stromal Cells As a Versatile Therapeutic Tool for Treating Multiple Sclerosis, Stem Cell Research and Therapy (2021)
6. Ellagic Acid Ameliorates Neuroinflammation and Demyelination in Experimental Autoimmune Encephalomyelitis: Involvement of Nlrp3 and Pyroptosis, Journal of Chemical Neuroanatomy (2021)
7. Smoking and Worsening Disability in Multiple Sclerosis: A Meta-Analysis, Acta Neurologica Scandinavica (2018)
8. Mesenchymal Stem Cells for Multiple Sclerosis (Mesems): A Randomized, Double Blind, Cross-Over Phase I/Ii Clinical Trial With Autologous Mesenchymal Stem Cells for the Therapy of Multiple Sclerosis, Trials (2019)
Experts (# of related papers)
View all Related Experts
Abdolreaza Naser Moghadasi (5)
Mohammad Ali Sahraian (4)
Other Related Docs
9. “Begging the Question”—Does Toxocara Infection/Exposure Associate With Multiple Sclerosis-Risk?, Pathogens (2020)
10. Immunopathogenesis of Multiple Sclerosis: Molecular and Cellular Mechanisms and New Immunotherapeutic Approaches, Immunopharmacology and Immunotoxicology (2024)
11. Deciphering the Bidirectional Impact of Leukocyte Telomere Length on Multiple Sclerosis Progression: A Mendelian Randomization Study, Multiple Sclerosis and Related Disorders (2025)
12. Progesterone Therapy Induces an M1 to M2 Switch in Microglia Phenotype and Suppresses Nlrp3 Inflammasome in a Cuprizone-Induced Demyelination Mouse Model, International Immunopharmacology (2017)
13. Prevalence and Predictors of Dysphagia in Iranian Patients With Multiple Sclerosis, Medical Journal of the Islamic Republic of Iran (2017)
14. Multiple Sclerosis Pathogenesis: Missing Pieces of an Old Puzzle, Reviews in the Neurosciences (2019)
15. Physical Activity Interventions Can Improve Emotion Regulation and Dimensions of Empathy in Persons With Multiple Sclerosis: An Exploratory Study, Multiple Sclerosis and Related Disorders (2020)
16. Increased Expression of Mir-301A in Pbmcs of Patients With Relapsing-Remitting Multiple Sclerosis Is Associated With Reduced Nkrf and Pias3 Expression Levels and Disease Activity, Journal of Neuroimmunology (2018)
17. The Role of Mitochondrial Dna Variants and Dysfunction in the Pathogenesis and Progression of Multiple Sclerosis, Mitochondrion (2025)
18. Mesenchymal Stromal Cell-Derived Secretome-Based Therapy for Neurodegenerative Diseases: Overview of Clinical Trials, Stem Cell Research and Therapy (2023)
19. Effectiveness of Acupuncture for Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Controlled Trial, Acupuncture in Medicine (2023)
20. Il-21 and Il-21-Producing T Cells Are Involved in Multiple Sclerosis Severity and Progression, Immunology Letters (2019)
21. The Role of Candida Albicans in the Severity of Multiple Sclerosis, Mycoses (2016)
22. Mind Diet Adherence Might Be Associated With a Reduced Odds of Multiple Sclerosis: Results From a Case–Control Study, Neurology and Therapy (2022)